Literature DB >> 16031672

Lethal osteogenesis imperfecta and skin fragility in newborn New Zealand Romney lambs.

D G Arthur1, K G Thompson, P Swarbrick.   

Abstract

Osteogenesis imperfecta and skin fragility occurred in about 50 New Zealand Romney lambs born in a flock of 450 ewes. Affected lambs had soft bones and multiple intrauterine bone fractures. Long bones had a thickened diaphysis with almost complete absence of a medullary cavity. Other consistent gross findings were moderate brachynathia inferior, subcutaneous oedema, marked joint laxity, dark blue sclera and small pink teeth. Histopathologic and ultrastructural changes were consistent with a defect in collagen production by fibroblasts. DNA finger-printing was used to identify which of the five rams used in the flock was carrying the genetic defect. The disease was inherited as an autosomal dominant trait and was considered to be a new mutation in the testicular germ cell lines of this ram.

Entities:  

Year:  1992        PMID: 16031672     DOI: 10.1080/00480169.1992.35712

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  4 in total

1.  Severe osteogenesis imperfecta caused by CREB3L1 mutation in a cat.

Authors:  Masamine Takanosu; Yumiko Kagawa
Journal:  J Vet Diagn Invest       Date:  2022-02-15       Impact factor: 1.569

Review 2.  Animal models of osteogenesis imperfecta and related syndromes.

Authors:  Agnès S Kamoun-Goldrat; Martine F Le Merrer
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

3.  Clinical application of quantitative computed tomography in osteogenesis imperfecta-suspected cat.

Authors:  Sungjun Won; Woo-Jo Chung; Junghee Yoon
Journal:  J Vet Sci       Date:  2017-09-30       Impact factor: 1.672

4.  Osteogenesis imperfecta in a male holstein calf associated with a possible oligogenic origin.

Authors:  Xuying Zhang; Marc Hirschfeld; Julia Beck; Alexandra Kupke; Kernt Köhler; Ekkehard Schütz; Bertram Brenig
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.